Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 13-18

  Levine, J E ^a,d   Wiley, J ^b   Kletzel, M ^c   Yanik, G ^a   Hutchinson, R J ^a   Koehler, M ^e   Neudorf, S ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^e NONE

Author keywords

Allogeneic transplantation; Childhood; GVHD; Peripheral blood stem cells

Indexed keywords

CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; STEROID; TACROLIMUS;

ADOLESCENT; ALLOGRAFT; ARTICLE; BLOOD DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; INFANT; KOSTMANN SYNDROME; LEUKAPHERESIS; MULTICENTER STUDY; PRIORITY JOURNAL; RELAPSE; RISK; STEM CELL TRANSPLANTATION; SURVIVAL; THALASSEMIA MAJOR; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; WISKOTT ALDRICH SYNDROME;

EID: 0033950180     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702081     Document Type: Article

References (17)

1. Henon PhR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after uutolugous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
2. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
3. Huan S, Hester J, Spitzer G et al. Influence of mobilized peripheral blood cells on the hematopoietic recovery of autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin. Blood 1992; 79: 3388-3393.
4. Leibundgut K, Hirt A, Ridolfi Lüthy A et al. Autotransplants with peripheral blood stem cells and clinical results obtained in children: a review. Eur J Pediatr 1993; 152: 546-554.
5. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
6. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
7. Champlin R, Schmitz N, Horowitz M. Allogeneic blood stem cell (BSC) vs. bone marrow transplantation (BMT): improved leukemia-free survival in high risk but not low risk patients. Blood 1998; 92 (Suppl. 1): 2710a.
8. Lickliter JD, DeFor T, Wagner JE et al. Matched-pair analysis of peripheral blood stein cells compared to marrow for allogeneic transplantation. Blood 1998; 92 (Suppl. 1): 561a.
9. Ottinger HD, Beelen DW, Sheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
10. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
11. Minero R, Busca A, Bonetti F et al. Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers. Bone Marrow Transplant 1998; 22 (Suppl. 5): S33-S36.
12. Diaz MA, Alegre A, Villa M et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies. Br J Haematol 1997; 96: 161-164.
13. Schriber JR, Chao NJ, Long GD et al. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood 1994; 84: 1680-1684.
14. Ringden O, Horowitz MM. Sondel P et al. Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
15. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft-versus-host disease after allogeneic peri-pheral blood progenitor cell transplantation. The Spanish Group of allo-PBPCT. Haematologica 1997; 82: 683-689.
16. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
17. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.